Drug that 'mutes' defective genes that cause nerve disorders effective in trials

Drug that ‘mutes’ defective genes that cause nerve disorders effective in trials

A crucial, late-stage clinical trial showed that the [nerve disorder drug patisiran] works—and that it’s safe. And now the biotech company ...
Asthma breakthrough? 'Blockbuster' Gleevec cancer drug shows promise in treating severe cases

Asthma breakthrough? ‘Blockbuster’ Gleevec cancer drug shows promise in treating severe cases

A blockbuster cancer drug may have a surprising new use: It’s showing real promise in treating severe asthma. That may ...
Sequencing pioneer sets sights on $100 genome

Sequencing pioneer sets sights on $100 genome

Next-gen sequencing pioneer Illumina says it may soon usher in the era of the $100 genome — which could, in ...
Personalized cancer treatments struggling to overcome patient deaths, severe side effects

Personalized cancer treatments struggling to overcome patient deaths, severe side effects

The idea is tantalizing: Reengineer a patient’s own immune cells to attack the cancer that’s killing her. Scientists have proven ...
Revolutionary CAR-T cancer therapy needs to nearly kill you to save you

Revolutionary CAR-T cancer therapy needs to nearly kill you to save you

[There is an] experimental therapy that...could rid [a patient's] body of cancer entirely. It’s called CAR-T therapy, and it works ...

FDA chief promotes new online tool for Precision Medicine Initiative

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. The Obama administration has ...
Breakthroughs in growing human tissue create excitement in biotech market

Breakthroughs in growing human tissue create excitement in biotech market

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. For decades, scientists and ...

Is Big Biotech starting to resemble Big Pharma?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. As drug developers and ...
Candy-flavored ADHD drug has doctors concerned over potential for abuse

Candy-flavored ADHD drug has doctors concerned over potential for abuse

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Adzenys, as the chewable, ...
Nanotechnology could lead to revolution in drug development

Nanotechnology could lead to revolution in drug development

Monoclonal antibody research skyrocketed in the 1980s. By the next decade, they hit the market and today, some of the ...